LINCOLN PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Lincoln Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.07₹ -0.4
As on Sep 16, 2025, 4:01 PM IST
Lincoln Pharmaceuticals Price Performance
Today's LowToday's High
₹548.05₹562.05
₹553.70
52 Weeks' Low52 Weeks' High
₹500.00₹975.00
₹553.70
Open Price
₹558.65
Prev. Close
₹554.10
Volume
4,656
Over the last 5 years, the share price of Lincoln Pharmaceuticals has gained 16.69% CAGR. Over the past year, the corresponding return has been -26.86%.
Lincoln Pharmaceuticals’s current P/E of 12.84x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Lincoln Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Lincoln Pharmaceuticals | -0.01 | 1.32 | -4.04 | 6.71 | -26.86 | 23.65 | 16.69 |
| Sun Pharmaceutical Industries | 0.99 | -1.32 | -4.43 | -5.58 | -13.53 | 22.86 | 25.44 |
| Divi's Laboratories | 1.35 | -1.39 | -9.09 | 7.26 | 10.98 | 19.38 | 13.39 |
| Cipla | 0.28 | -0.53 | 1.92 | 4.23 | -6.24 | 14.18 | 15.63 |
| Torrent Pharmaceuticals | -2.95 | -3.25 | 7.81 | 15.50 | 2.38 | 33.75 | 19.96 |
| Dr. Reddy's Laboratories | 1.32 | 3.70 | -2.69 | 13.92 | -1.44 | 17.09 | 7.19 |
| Mankind Pharma | -0.83 | 3.97 | 8.45 | 18.23 | 4.55 | 21.72 | 12.52 |
| Zydus Lifesciences | -0.29 | 4.77 | 6.12 | 15.71 | -7.35 | 42.05 | 21.62 |
| Lupin | 4.71 | 4.15 | 2.02 | 3.02 | -8.93 | 48.04 | 14.81 |
| Abbott India | 1.23 | -4.93 | -2.02 | 2.81 | 6.44 | 20.90 | 13.41 |
| Alkem Laboratories | 3.35 | 3.02 | 13.21 | 14.40 | -13.33 | 20.01 | 14.29 |
| Aurobindo Pharma | 4.59 | 0.18 | -4.54 | -1.88 | -30.10 | 26.95 | 5.60 |
| Glenmark Pharmaceuticals | -1.88 | 5.17 | 23.41 | 45.12 | 19.22 | 77.31 | 32.95 |
| Laurus Labs | -0.79 | 3.44 | 31.66 | 53.95 | 77.42 | 20.10 | 27.14 |
| Biocon | -1.25 | -1.13 | 0.78 | 7.85 | -7.84 | 7.35 | -3.86 |
| Anthem Biosciences | 1.45 | 3.75 | 13.75 | 13.75 | 13.75 | 4.39 | 2.61 |
| GlaxoSmithKline Pharmaceuticals | -2.60 | -1.60 | -18.46 | 1.95 | -3.00 | 24.23 | 9.16 |
| Cohance Lifesciences | -2.90 | 10.08 | -0.45 | -12.87 | -15.54 | 28.96 | 21.52 |
| Gland Pharma | 5.31 | 2.52 | 14.26 | 30.13 | 8.35 | -4.11 | 2.12 |
| Ipca Laboratories | -0.61 | -5.32 | -3.76 | -0.34 | -10.15 | 14.97 | 3.52 |
Over the last one year, Lincoln Pharmaceuticals has declined 26.86% compared to peers like Sun Pharmaceutical Industries (-13.53%), Divi's Laboratories (10.98%), Cipla (-6.24%). From a 5 year perspective, Lincoln Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 557.97 | 555.43 |
| 10 | 553.37 | 554.51 |
| 20 | 550.75 | 552.87 |
| 50 | 552.03 | 554.26 |
| 100 | 561.88 | 566.42 |
| 200 | 623.6 | 591.54 |
Lincoln Pharmaceuticals Share Holding Pattern
In the latest quarter, Lincoln Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 0.01%, FII holding rose to 5.13%, and public shareholding moved down to 45.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Lincoln Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 230 | 0.04 | 0.01 |
Lincoln Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 06, 2025, 9:47 PM IST | Lincoln Pharmace - General Updates |
| Sep 06, 2025, 8:44 PM IST | Lincoln Pharmace - Reg. 34 (1) Annual Report. |
| Sep 06, 2025, 7:31 PM IST | Lincoln Pharmace - Notice Of 31St Annual General Meeting Of The Company. |
| Aug 29, 2025, 10:38 PM IST | Lincoln Pharmace - Announcement under Regulation 30 (LODR)-Change in Management |
| Aug 29, 2025, 4:58 PM IST | Lincoln Pharmace - Intimation Of Book Closure And Record Date For The Purpose Of 31St Annual General Meeting And Final Divide |
About Lincoln Pharmaceuticals
Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 623.23 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressLincoln House, Ahmedabad Gujarat 380060
- Contact
Management
- Mr. Kishor M ShahNon Executive Chairman
- Mr. Mahendra G PatelManaging Director
- Mr. Hashmukh I PatelWhole Time Director
- Mr. Munjal M PatelWhole Time Director
- Mr. Ashish R PatelWhole Time Director
- Mr. Rajnikant G PatelNon Executive Director
- Mr. Nareshkumar SutharIndependent Director
- Mr. Saurin J ParikhIndependent Director
- Ms. Seema MehtaIndependent Director
FAQs on Lincoln Pharmaceuticals Share Price
What is the share price of Lincoln Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Lincoln Pharmaceuticals is ₹553.70 as on Sep 16, 2025.
What kind of stock is Lincoln Pharmaceuticals?
The Lincoln Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Lincoln Pharmaceuticals?
The market cap of Lincoln Pharmaceuticals is ₹1,109.05 Cr as on Sep 16, 2025.
What are today's High and Low prices of Lincoln Pharmaceuticals?
Today’s highest and lowest price of Lincoln Pharmaceuticals are ₹562.05 and ₹548.05.
What are the 52 Week High and 52 Week Low of Lincoln Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Lincoln Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Lincoln Pharmaceuticals is ₹975.00 and 52-week low of Lincoln Pharmaceuticals is ₹500.00 as on Sep 16, 2025.
How has the Lincoln Pharmaceuticals performed historically in terms of returns?
The Lincoln Pharmaceuticals has shown returns of -0.07% over the past day, 1.32% for the past month, -4.04% over 3 months, -26.86% over 1 year, 23.65% across 3 years, and 16.69% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Lincoln Pharmaceuticals?
P/E ratio of and PB ratio of Lincoln Pharmaceuticals are 12.84 and 1.73 on Sep 16, 2025. While the company gives a dividend yield of 0.33 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data